|
Concur with Lani
Nice research presented Lani...ask for the TOPOII test to determine if AC therapy would be indicated. Should you test negative for TOPOII, perhaps you may consider the less toxic chemotherapy,CMF which may be indicated with your relatively low risk of relapse. And let me just say, CMF has proven to decrease her2 bc relapse, albeit somewhat less than AC. See for yourself, google the research paper from Edith Perez for confirmation of this if you like.
Additionally, perhaps you would consider the 9 week regimen of Herceptin which had no cardiac risks in three year follow-up. I know that a clinic in FL is offering this option for very early stage her2+ bc and for late adjuvant Herceptin. Nine weeks may be adequate for those in the gray zone where the relative benefits of herceptin adjuvant therapy is unknown and the side effects of therapy less. By the way, I had very early stage her2+ breast cancer too and took CMF and tried the late adjuvant 9 week Herceptin Regimen.
|